Rheumatoid Arthritis in the Elderly: A Distinct Clinical Entity?

Citation: 

Pages 5 - 6

Authors: 

Aviva Hopkins, MD, and Carlos J. Lozada, MD

 

This article is no longer available for CME credit.

 

Release Date: January 15, 2008
Expiration Date: January 15, 2009

TARGET AUDIENCE
Internists, family practitioners, geriatricians, cardiologists, and others who care for older patients.

MEDIUM USED & METHOD OF PARTICIPATION
Read the article, complete the evaluation and post-test, and return both to: NACCME via fax at (610) 560-0502. You will receive your certificate in 6-8 weeks. If you would like to print your certificate immediately, go to http://cme.naccme.com, register as a NACCME user and access the activity test and evaluation online.

SUCCESSFUL COMPLETION
Successful completion entails participants obtaining a score of at least 70% on the post-test. A certificate of completion will be mailed to the address listed on your post-test/evaluation form within 6-8 weeks of receipt of the documents.

References: 

1. Kerr LD. Inflammatory arthropathy: A review of rheumatoid arthritis in older patients. Geriatrics 2004;59:32-362. Rasch EK, Hirsch R, Paulose-Ram R, Hochberg MC. Prevalence of rheumatoid arthritis in persons 60 years of age and older in the United States: Effect of different methods of case classification. Arthritis Rheum 2003;48:917-926.3. Schnell A. The clinical features of rheumatic infection in the old. Acta Med Scand 1941;106:345-351.4. Cecil RL, Kammerer WH. Rheumatoid arthritis in the aged. Am J Med 1951;10:439-445.5. Brown JW, Sones DA. The onset of rheumatoid arthritis in the aged. J Am Geriatr Soc 1967;15:873-881.6. Moesmann G. Clinical features in subacute rheumatoid arthritis in old age. Acta Rheumatol Scand 1968;14:285-297.7. Corrigan AB, Robinson RG, Terenty TR, et al. Benign rheumatoid arthritis of the aged. Br Med J 1974;1:444-446.8. Narayanan K, Rajendran CP, Porkodi R, Madhavan R. Late onset rheumatoid arthritis—A clinical and laboratory study. J Assoc Physicians India 2001;49:311-313.9. Turkcapar N, Demir O, Atli T, et al. Late onset rheumatoid arthritis: Clinical and laboratory comparisons with younger onset patients. Arch Gerontol Geriatr 2006;42:225-231. Epub 2005 Sep 26.10. Pease CT, Bhakta BB, Devlin J, Emery P. Does the age of onset of rheumatoid arthritis influence phenotype?: A prospective study of outcome and prognostic factors. Rheumatology (Oxford) 1999;38:228-234.11. van Schaardenburg D, Breedveld FC. Elderly-onset rheumatoid arthritis. Semin Arthritis Rheum 1994;23:367-378.12. Graudal N, Tarp U, Jurik AG, et al. Inflammatory patterns in rheumatoid arthritis estimated by the number of swollen and tender joints, the erythrocyte sedimentation rate, and hemoglobin: Longterm course and association to radiographic progression. J Rheumatol 2000;27:47-5713. Jansen LM, van der Horst-Bruinsma IE, van Schaardenburg D, et al. Predictors of radiographic joint damage in patients with early rheumatoid arthritis. Ann Rheum Dis 2001;60:924-927.14. Inoue K, Shichikawa K, Nishioka J, Hirota S. Older age onset rheumatoid arthritis with or without osteoarthritis. Ann Rheum Dis 1987;46:908-911.15. Shearn MA, Kang IY. Effect of age and sex on the erythrocyte sedimentation rate. J Rheumatol 1986;13:297-298.16. Wernick R. Avoiding laboratory test misinterpretation in geriatric rheumatology. Geriatrics 1989;44:61-63, 67-68, 73-7817. Wener MH, Daum PR, McQuillan GM. The influence of age, sex, and race on the upper reference limit of serum C-reactive protein concentration. J Rheumatol 2000;27:2351-2359..18. Ranganath V, Elashoff D, Khanna D, et al; Western Consortium of Practicing Rheumatologists. Age adjustment corrects for apparent differences in erythrocyte sedimentation rate and C-reactive protein values at the onset of seropositive rheumatoid arthritis in younger and older patients. J Rheumatol 2005;32:1040-1042.19. Khanna D, Ranganath VK, Fitzgerald J, et al; Western Consortium of Practicing Rheumatologists. Increased radiographic damage scores at the onset of seropositive rheumatoid arthritis in older patients are associated with osteoarthritis of the hands, but not with more rapid progression of damage. Arthritis Rheum 2005;52:2284-2292.20. Glennas A, Kvien TK, Andrup O, et al. Recent onset arthritis in the elderly: A 5 year longitudinal observational study. J Rheumatol 2000;27:101-108.21. van der Heijde DM, van Riel PL, van Leeuwen MA, et al. Older versus younger onset rheumatoid arthritis: Results at onset and after 2 years of a prospective follow-up study of early rheumatoid arthritis. J Rheumatol 1991;18:1285-1289.22. Ferraccioli GF, Cavalieri F, Mercadanti, M, et al. Clinical features, scintiscan characteristics and X-ray progression of late onset rheumatoid arthritis. Clin Exp Rheumatol 1984;2:157-161.23. Terkeltaub J, Esdaile J, Decary F, Tannenbaum H. A clinical study of older age rheumatoid arthritis with comparison to a younger onset group. J Rheumatol 1983;10:418-424.24. van Schaardenburg D, Hazes JM, de Boer A, et al. Outcome of rheumatoid arthritis in relation to age and rheumatoid factor at diagnosis. J Rheumatol 1993;20:45-52.25. Yazici Y, Paget SA. Elderly-onset rheumatoid arthritis. Rheum Dis Clin North Am 2000;26:517-526.26. Mikuls T, Saag K, Criswell L, et al. Health related quality of life in women with elderly onset rheumatoid arthritis. J Rheumatol 2003;30:952-957.27. Ceccato F, Roverano S, Barrionuevo A, et al. The role of anticyclic citrullinated peptide antibodies in the differential diagnosis of elderly-onset rheumatoid arthritis and polymyalgia rheumatica. Clin Rheumatol 2006;25:854-857. Epub 2006 Mar 2.28. Lopez-Hoyos M, Ruiz de Alegria C, Blanco R, et al. Clinical utility of anti-CCP antibodies in the differential diagnosis of elderly-onset rheumatoid arthritis and polymyalgia rheumatica. Rheumatology (Oxford) 2004;43:655-657.29. McGonagle D, Pease C, Marzo-Ortega H, et al. Comparison of extracapsular changes by magnetic resonance imaging in patients with rheumatoid arthritis and polymyalgia rheumatica. J Rheumatol 2001;28:1837-1841.30. Pease CT, Haugeberg G, Morgan AW, et al. Diagnosing late onset rheumatoid arthritis, polymyalgia rheumatica, and temporal arteritis in patients presenting with polymyalgic symptoms. A prospective longterm evaluation. J Rheumatol 2005;32(6):1043-1046. [Erratum in: J Rheumatol 2005:32(9):1852.]31. Ranganath VK, Furst DE. Disease-modifying antirheumatic drug use in the elderly rheumatoid arthritis patient. Clin Geriatr Med 2005;21:649-669, viii. 32. Tutuncu Z, Kavanaugh A. Rheumatic disease in the elderly: Rheumatoid arthritis. Clin Geriatr Med 2005;21:513-525, vi.33. Olivieri I, Palazzi C, Peruz G, Padula A. Management issues with elderly-onset rheumatoid arthritis: An update. Drugs Aging 2005;22:809-822.34. van Schaardenburg DM. Rheumatoid arthritis in the elderly. Prevalence and optimal management. Drugs Aging 1995;7:30-37.35. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. American College of Rheumatology Task Force on Osteoporosis Guidelines. Arthritis Rheum 1996;39:1791-1801.36. Bologna C, Viu P, Jorgensen C, Sany J. Effect of age on the efficacy and tolerance of methotrexate in rheumatoid arthritis. Br J Rheumatol 1996;35:453-457.37. Gardner G, Furst DE. Disease modifying antirheumatic drugs. Potential effects in older patients. Drugs Aging 1995;7:420-437. 38. Beyth RJ, Shorr RI. Principles of drug therapy in older patients: Rational drug prescribing. Clin Geriatr Med 2002;18:577-592.39. Fleischmann RM, Baumgartner SW, Tindall EA, et al. Response to etanercept (Enbrel) in elderly patients with rheumatoid arthritis: A retrospective analysis of clinical trial results. J Rheumatol 2003;30:691-696.40. Bathon JM, Fleischmann RM, Van der Heijde D, et al. Safety and efficacy of etanercept treatment in elderly subjects with rheumatoid arthritis. J Rheumatol 2006;33:234-243.41. Fleischmann RM, Baumgartner SW, Weisman MH, et al. Long term safety of etanercept in elderly subjects with rheumatic diseases. Ann Rheum Dis 2006;65:379-384. Epub 2005 Sep 8.42. Hyrich KL, Watson KD, Silman AJ, Symmons DP; British Society for Rheumatology Biologics Register. Predictors of response to anti-TNF-alpha-therapy among patients with rheumatoid arthritis: Results from the British Society for Rheumatology Biologics Register. Rheumatology (Oxford) 2006;45:1558-1565. Epub 2006 May 16.43. Chevillotte-Maillard H, Ornetti P, Mistrih R, et al. Survival and safety of treatment with infliximab in the elderly population. Rheumatology (Oxford) 2005;44:695-696.44. Dabbous O, Rahman MI, Gilmer K, et al. Impact of age on outcomes of Japanese patients with rheumatoid arthritis treated with infliximab: The Post Marketing Surveillance Trial. Ann Rheum Dis 2007;66(Suppl II):631.45. Mariette X, Tony HP, Ballina-Garcia FJ, et al. Treatment with adalimumab (Humira) is well-tolerated and efficacious in patients with active RA in various age groups including patients with late-onset RA: Subanalysis of 6610 Patients in the ReAct Trial. Arthritis Rheum 2006;54(Suppl):S242.46. Schneeweiss S, Setoguchi S, Weinblatt ME, et al. Anti-tumor necrosis factor alpha therapy and the risk of serious bacterial infections in elderly patients with rheumatoid arthritis. Arthritis Rheum 2007;56:1754-1764.47. Tutuncu Z, Reed G, Kremer J, Kavanaugh A. Do patients with older-onset rheumatoid arthritis receive less aggressive treatment? Ann Rheum Dis 2006;65:1226-1229. Epub 2006 Jan 13.48. Calvo-Alen J, Corrales A, Sanchez-Andrada S, et al. Outcome of late-onset rheumatoid arthritis. Clin Rheumatol 2005;24:485-489. Epub 2005 Mar 5..



Post new comment

(If you're a human, don't change the following field)
Your first name.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
  • Use to create page breaks.

More information about formatting options

Image CAPTCHA
Enter the characters shown in the image.